Koninklijke DSM N.V. - BIO 300 - Ownership and Business Overview

Life ScienceCompany

Koninklijke DSM N.V. - BIO 300 Ownership

Who owns Koninklijke DSM N.V. - BIO 300?

Koninklijke DSM N.V. - BIO 300 is owned by Humanetics. It was acquired on February 19, 2020.

Koninklijke DSM N.V. - BIO 300 Business Overview

Where is Koninklijke DSM N.V. - BIO 300 headquartered?

Koninklijke DSM N.V. - BIO 300 is headquartered in Swaziland.

What sector is Koninklijke DSM N.V. - BIO 300 in?

Koninklijke DSM N.V. - BIO 300 is a life science company.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 285 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 262 by strategics.

Koninklijke DSM N.V. (Royal DSM) - BIO 300


Swaziland,

Koninklijke DSM N.V. (Royal DSM) - BIO 300 is a clinical-stage drug under development to protect normal tissues from the harm caused by radiation. The drug’s radioprotective effects were originally discovered by researchers within the Department of Defense at the Armed Forces Radiobiology Research Institute.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Koninklijke DSM N.V. - BIO 300

Life Science Companies , Swaziland Companies